Assessments
TNF-α
BLOOD

Blood samples were taken from all 122 patients in the treatment and placebo groups on day zero (before medicines consumption), at discharge, and 28 days after consumption (end of the treatment) to measure biochemical indices (Table Eleven patients from each group (22 samples in total) were randomly selected to measure serum levels of INF-γ, TNF-α, and IL-6 cytokines before the start of the study, at discharge, and after the end of the treatment. ELISA kits were used to measure TNFα (R&D Systems, UK), IFNγ (Thermo Fisher, Waltham, Massachusetts, USA), and IL-6 (R&D Systems, UK) according to the manufacturer’s instructions [The clinical symptoms of all the patients were recorded according to an assessment questionnaire (Table Titles of laboratory testsTitles of clinical score